740 related articles for article (PubMed ID: 11311991)
1. Solid lipid nanoparticles: production, characterization and applications.
Mehnert W; Mäder K
Adv Drug Deliv Rev; 2001 Apr; 47(2-3):165-96. PubMed ID: 11311991
[TBL] [Abstract][Full Text] [Related]
2. Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system.
Kalam MA; Sultana Y; Ali A; Aqil M; Mishra AK; Chuttani K
J Drug Target; 2010 Apr; 18(3):191-204. PubMed ID: 19839712
[TBL] [Abstract][Full Text] [Related]
3. Novel approach for overcoming the stability challenges of lipid-based excipients. Part 3: Application of polyglycerol esters of fatty acids for the next generation of solid lipid nanoparticles.
Corzo C; Meindl C; Lochmann D; Reyer S; Salar-Behzadi S
Eur J Pharm Biopharm; 2020 Jul; 152():44-55. PubMed ID: 32387704
[TBL] [Abstract][Full Text] [Related]
4. Solid lipid nanoparticles (SLN) for controlled drug delivery. II. Drug incorporation and physicochemical characterization.
Schwarz C; Mehnert W
J Microencapsul; 1999; 16(2):205-13. PubMed ID: 10080114
[TBL] [Abstract][Full Text] [Related]
5. Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems.
Uner M
Pharmazie; 2006 May; 61(5):375-86. PubMed ID: 16724531
[TBL] [Abstract][Full Text] [Related]
6. Stability of lipid excipients in solid lipid nanoparticles.
Radomska-Soukharev A
Adv Drug Deliv Rev; 2007 Jul; 59(6):411-8. PubMed ID: 17553589
[TBL] [Abstract][Full Text] [Related]
7. Spray-drying of solid lipid nanoparticles (SLN TM).
Freitas C; Müllerä RH
Eur J Pharm Biopharm; 1998 Sep; 46(2):145-51. PubMed ID: 9795036
[TBL] [Abstract][Full Text] [Related]
8. Effect of freeze-drying, cryoprotectants and storage conditions on the stability of secondary structure of insulin-loaded solid lipid nanoparticles.
Soares S; Fonte P; Costa A; Andrade J; Seabra V; Ferreira D; Reis S; Sarmento B
Int J Pharm; 2013 Nov; 456(2):370-81. PubMed ID: 24036086
[TBL] [Abstract][Full Text] [Related]
9. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
[TBL] [Abstract][Full Text] [Related]
10. The use of solid lipid nanoparticles for sustained drug release.
Attama AA; Umeyor CE
Ther Deliv; 2015; 6(6):669-84. PubMed ID: 26149784
[TBL] [Abstract][Full Text] [Related]
11. Spray freeze drying as an alternative technique for lyophilization of polymeric and lipid-based nanoparticles.
Ali ME; Lamprecht A
Int J Pharm; 2017 Jan; 516(1-2):170-177. PubMed ID: 27845211
[TBL] [Abstract][Full Text] [Related]
12. Influence of different parameters on reconstitution of lyophilized SLN.
Zimmermann E; Müller RH; Mäder K
Int J Pharm; 2000 Mar; 196(2):211-3. PubMed ID: 10699720
[TBL] [Abstract][Full Text] [Related]
13. Characterization of ergocalciferol loaded solid lipid nanoparticles.
Patel MR; San Martin-Gonzalez MF
J Food Sci; 2012 Jan; 77(1):N8-13. PubMed ID: 22260120
[TBL] [Abstract][Full Text] [Related]
14. Characterization and stability of nanostructured lipid carriers as drug delivery system.
Abbasalipourkabir R; Salehzadeh A; Abdullah R
Pak J Biol Sci; 2012 Feb; 15(3):141-6. PubMed ID: 22866544
[TBL] [Abstract][Full Text] [Related]
15. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy.
Jores K; Mehnert W; Drechsler M; Bunjes H; Johann C; Mäder K
J Control Release; 2004 Mar; 95(2):217-27. PubMed ID: 14980770
[TBL] [Abstract][Full Text] [Related]
16. Solid lipid nanoparticles (SLN) and oil-loaded SLN studied by spectrofluorometry and Raman spectroscopy.
Jores K; Haberland A; Wartewig S; Mäder K; Mehnert W
Pharm Res; 2005 Nov; 22(11):1887-97. PubMed ID: 16132349
[TBL] [Abstract][Full Text] [Related]
17. Influence of surfactants on the physical stability of solid lipid nanoparticle (SLN) formulations.
Uner M; Wissing SA; Yener G; Müller RH
Pharmazie; 2004 Apr; 59(4):331-2. PubMed ID: 15125588
[TBL] [Abstract][Full Text] [Related]
18. Preparation of lipid nanoparticles with high loading capacity and exceptional gastrointestinal stability for potential oral delivery applications.
Wang T; Xue J; Hu Q; Zhou M; Luo Y
J Colloid Interface Sci; 2017 Dec; 507():119-130. PubMed ID: 28780331
[TBL] [Abstract][Full Text] [Related]
19. Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye - Part II - Ocular drug-loaded lipid nanoparticles.
Sánchez-López E; Espina M; Doktorovova S; Souto EB; García ML
Eur J Pharm Biopharm; 2017 Jan; 110():58-69. PubMed ID: 27789359
[TBL] [Abstract][Full Text] [Related]
20. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
Müller RH; Mäder K; Gohla S
Eur J Pharm Biopharm; 2000 Jul; 50(1):161-77. PubMed ID: 10840199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
